Introduction
============

Mounting evidence suggests that leukocyte telomere length (LTL) is a bio-indicator of human aging, cardiovascular aging in particular. LTL is heritable ([@b58]; [@b39]; [@b64]; [@b5]), although it is unknown how much of this heritability relates to birth LTL and the rate of its shortening from birth onward. Age-dependent LTL shortening is due to successive divisions of hematopoietic stem cells (HSCs) and progenitor cells (PCs) that form peripheral leukocytes. Inflammation and oxidative stress -- two central elements in the biology of aging and aging-related diseases ([@b28]; [@b12]) -- were reported to be associated with LTL ([@b7]; [@b26]; [@b13]; [@b29]). Inflammation entails an increase in number and diminished biological life of leukocyte subsets in the circulation, which would heighten the demand on HSCs/PCs to replicate, a phenomenon expressed in an accelerated telomere attrition and ultimately shortened LTL. Oxidative stress heightens the loss of telomere repeats per cell division ([@b57]; [@b56]; [@b61]). The compounded effect of inflammation/oxidative stress on the paces of both aging and LTL attrition conceivably explains the shortened LTL observed in individuals with aging-related diseases, particularly atherosclerotic cardiovascular (CV) disease ([@b18]; [@b22]; [@b14]; [@b45]; [@b46]; [@b17]; [@b29]; [@b36]), which is strongly linked to inflammation ([@b34]).

The paradigm that links LTL to CV disease draws on data derived mainly from non-African American populations. But the developmental pattern of CV disease differs between African Americans and whites. For instance, African Americans are more prone to heart failure due to hypertension ([@b69]; [@b66]), but they have considerably less coronary artery calcification than do whites ([@b60]; [@b68]; [@b48]; [@b1]; [@b42]). We therefore explored in two ongoing studies, the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study (FHS) and the Bogalusa Heart Study (BHS), the racial effect on LTL.

Results
=======

Mean ages and BMI of whites and African Americans, by sex, are displayed in [Table 1](#tbl1){ref-type="table"}. In both the FHS and the BHS cohorts, LTL, measured by Southern blots of the terminal restriction fragment (TRF) products of *Hin*fI/*Rsa*I, was significantly longer in African Americans than in whites ([Table 2](#tbl2){ref-type="table"}; [Fig. 1](#fig01){ref-type="fig"}). As LTL was inversely correlated to BMI (*r* = --0.071, *p* = 0.002), we adjusted LTL for the BMI. For the FHS cohort, sex-specific differences in age- and BMI-adjusted LTL between African Americans and whites were 180 base pairs (bp) for men and 320 bp for women; for the BHS cohort, these differences amounted to 500 bp for men and 680 bp for women. Heritability of LTL in whites was 0.69 ± 0.03, while in African Americans it was 0.78 ± 0.09, both significant at *p* \< 0.0001. There was no statistically significant difference in heritability between African Americans and whites.

###### 

Leukocyte telomere parameters by race and sex in the two cohorts, in which leukocyte telomere length (LTL) was measured using restriction enzymes *Hin*fI/*Rsa*I

                              Whites        African Americans                                           
  --------------------------- ------------- ------------------- ------------- ------------- ----------- -----------
  FHS                                                                                                   
  LTL                         6.67 ± 0.03   6.77 ± 0.03         6.93 ± 0.05   7.16 ± 0.04   \< 0.0001   \< 0.0001
  Age-adjusted LTL            6.68 ± 0.03   6.81 ± 0.03         6.86 ± 0.05   7.10 ± 0.03   \< 0.0001   \< 0.0001
  Age- and BMI-adjusted LTL   6.68 ± 0.03   6.80 ± 0.03         6.86 ± 0.04   7.12 ± 0.04   \< 0.0001   \< 0.0001
  BHS                                                                                                   
  LTL                         7.28 ± 0.06   7.32 ± 0.05         7.81 ± 0.10   7.95 ± 0.08   0.5087      \< 0.0001
  Age-adjusted LTL            7.29 ± 0.06   7.31 ± 0.05         7.83 ± 0.11   7.93 ± 0.08   0.5241      \< 0.0001
  Age- and BMI-adjusted LTL   7.30 ± 0.06   7.29 ± 0.05         7.84 ± 0.11   7.97 ± 0.08   0.2590      \< 0.0001

BMI, body mass index; BHS, Bogalusa Heart Study; FHS, Family Heart Study.

###### 

Means (± standard deviation) of age and body mass index of the two cohorts

                               Whites        African Americans   Entire sample                               
  ---------------------------- ------------- ------------------- --------------- ------------- ------------- --------------
  FHS                          (*n* = 610)   (*n* = 785)         (*n* = 195)     (*n* = 378)   (*n* = 805)   (*n* = 1163)
  Age (years)                  57.3 ± 13.6   58.5 ± 13.1         52.4 ± 10.6     54.0 ± 10.9   56.1 ± 13.1   57.1 ± 12.6
  Body mass index (kg m^−2^)   29.4 ± 4.7    28.4 ± 5.9          30.6 ± 6.1      34.1 ± 7.8    29.7 ± 5.1    30.2 ± 7.1
  BHS                          (*n* = 140)   (*n* = 207)         (*n* = 44)      (*n* = 94)    (*n* = 184)   (*n* = 301)
  Age (years)                  30.9 ± 4.6    30.1 ± 4.8          31.6 ± 3.9      29.4 ± 5.0    31.1 ± 4.4    30.0 ± 4.9
  Body mass index (kg m^−2^)   27.8 ± 5.3    25.5 ± 6.1          28.6 ± 8.2      30.6 ± 8.6    28.0 ± 6.1    27.1 ± 7.4

BHS, Bogalusa Heart Study; FHS, Family Heart Study.
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In the FHS cohort, women of both races displayed significantly longer LTL than men ([Table 2](#tbl2){ref-type="table"}; [Fig. 1](#fig01){ref-type="fig"}). The sex-related differences in age- and BMI-adjusted LTL for this cohort were 120 bp for whites and 260 bp for African Americans. However, no such difference was noted between women and men of both races in the relatively younger BHS cohort ([Table 2](#tbl2){ref-type="table"}; [Fig. 1](#fig01){ref-type="fig"}). Further details regarding LTL results derived from the *Hin*fI/*Rsa*I digest are summarized in [Table 2](#tbl2){ref-type="table"}.

In most clinical studies, the restriction enzymes for TRF analysis typically comprise *Hin*fI/*Rsa*I. In principle, longer LTL in African Americans than in whites may arise from race-related polymorphisms in length or the nearest restriction site proximal to the canonic (TTAGGG) stretch of the telomeric repeats. For this reason we also measured in a subset of the BHS cohort TRF length using the restriction enzymes *Hph*I/*MnI*I. Both restriction enzymes *Hin*fI/*Rsa*I and *Hph*I/*MnI*I yield an admixture of TRFs comprising primarily canonical but also some noncanonical telomere repeats at the proximal region of the telomeres. However, *Hph*I/*MnI*I cut the DNA at TGAGGG and TCAGGG, yielding shorter TRFs than those generated by *Hin*fI/*Rsa*I ([@b3]; [@b10]). This is shown in [Fig. 2](#fig02){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"} (and in Supplementary [Fig. S1](#SD1){ref-type="supplementary-material"}). In this subset, we also measured telomeric DNA content by quantitative polymerase chain reaction (qPCR) analysis, which strictly quantifies telomere repeats. Regardless of the method used, African Americans displayed longer LTL (or a higher T/S ratio) than whites ([Fig. 2](#fig02){ref-type="fig"}; also see [Table 3](#tbl3){ref-type="table"}). We note that the qPCR method ([@b21]) has a higher CV% than the TRF length analysis, which might limit detection of small variation in telomere length ([@b8]). However, given the considerable difference in LTL between African Americans and whites, the qPCR measurements confirmed the findings of the TRF length analysis. Interestingly, analysis of the TRF products generated by the *Hph*I/*MnI*I digest showed a significant sex effect on LTL in the BHS.

###### 

Leukocyte telomere parameters in a subset of the Bogalusa Heart Study by race and sex in which leukocyte telomere length (LTL) and telomere repeats were measured using restriction enzymes *Hin*fI/*Rsa*I and *Hph*I/*MnI*I, and by quantitative polymerase chain reaction (qPCR)

                              Bogalusa Heart Study                                                      
  --------------------------- ---------------------- ------------- ------------- ------------- -------- -----------
  LTL (*Hin*fI/*Rsa*I) (kb)                                                                             
  Unadjusted                  7.15 ± 0.13            7.25 ± 0.08   7.80 ± 0.11   7.91 ± 0.08   0.4702   \< 0.0001
  Age-adjusted                7.16 ± 0.12            7.24 ± 0.08   7.81 ± 0.12   7.91 ± 0.08   0.3878   \< 0.0001
  Age- and BMI-adjusted       7.14 ± 0.12            7.20 ± 0.08   7.82 ± 0.12   7.95 ± 0.08   0.3748   \< 0.0001
  LTL (*Hph*I*/MnI*I) (kb)                                                                              
  Unadjusted                  5.59 ± 0.13            5.79 ± 0.08   6.07 ± 0.13   6.32 ± 0.08   0.0292   \< 0.0001
  Age-adjusted                5.61 ± 0.12            5.78 ± 0.08   6.08 ± 0.12   6.31 ± 0.08   0.0637   \< 0.0001
  Age- and BMI-adjusted       5.58 ± 0.13            5.74 ± 0.08   6.10 ± 0.12   6.34 ± 0.08   0.0503   \< 0.0001
  qPCR LTL (T/S units)                                                                                  
  Unadjusted                  2.71 ± 0.08            2.71 ± 0.05   3.01 ± 0.10   3.05 ± 0.06   0.7923   \< 0.0001
  Age-adjusted                2.69 ± 0.09            2.72 ± 0.06   2.99 ± 0.08   3.06 ± 0.06   0.4788   \< 0.0001
  Age- and BMI-adjusted       2.68 ± 0.09            2.70 ± 0.06   2.99 ± 0.09   3.08 ± 0.06   0.4449   \< 0.0001

BMI, body mass index.
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We also obtained the overall and differential counts of leukocytes and their subsets, including neutrophils, in the majority of participants of the BHS whose telomere parameters were measured (Supplementary [Table S1](#SD1){ref-type="supplementary-material"}). Although African Americans showed significantly lower leukocyte and neutrophil counts than did whites, no relationships were observed between these counts and LTL in African Americans and whites, independently or jointly.

[Figure 3](#fig03){ref-type="fig"} displays sex- and BMI-adjusted LTL vs. age from the combined data set of the FHS and BHS, using LTL derived from *Hin*fI/*Rsa*I digest. African Americans had higher LTL at nearly all ages. However, sex- and BMI-adjusted LTL became shorter with age at a steeper slope in African Americans (0.029 kb year^−1^) than in whites (0.020 kb year^−1^) (*p* = 0.0001). The slope of LTL vs. age did not differ by sex.

![Sex- and body mass index-adjusted leukocyte telomere length (LTL) vs. age for African Americans and whites from the NHLBI Family Heart Study (FHS) and the Bogalusa Heart Study (BHS) combined.](acel0007-0451-f3){#fig03}

Discussion
==========

The central finding of this study is that African Americans have considerably longer LTL than whites, at least up to age 80. In this study, we observed a sex effect on LTL in the NHLBI FHS, but in the BHS, the sex effect was found only in the products of the *Hph*I/*MnI*I. A potential explanation for the difficulty in detecting the sex effect may be the much younger age of the BHS participants. In the FHS and in previous studies that found longer LTL in women than men ([@b39]; [@b15]; [@b49]; [@b64]; [@b13]), the subjects were much older than those in the BHS.

LTL is equal in African American and white newborns ([@b51]). As African Americans in their 20s already display longer LTL than their white peers, the racial gap in LTL might relate to factors that define leukocyte telomere dynamics during the formative years. These include the proliferative rates of HSCs/PCs. African Americans and other individuals of African ancestry display lower leukocyte and neutrophil counts than do whites ([@b33]; [@b9]; [@b53]; [@b47]), a finding we confirmed in the BHS. The neutrophils in peripheral blood are distributed into two pools; namely, circulating cells and marginated cells that adhere to the endothelium in postcapillary venules ([@b6]). Physiological neutropenia in individuals of African ancestry is not due to increased margination of neutrophils ([@b6]; [@b9]; [@b53]). It is therefore likely to arise from fewer replications of HSCs/PCs. The longer LTL in African Americans than in whites is consistent with this premise.

Telomere length is shorter in neutrophils than in T lymphocytes in young individuals and vice versa in older individuals ([@b65]). For the following reasons, we suggest that in and of itself this phenomenon does not explain the racial difference in LTL: First, LTL was found to be longer in African Americans than in whites at a wide age range that encompasses most of adult life. Second, there are considerable interindividual variations in LTL at birth ([@b51]; [@b2]) and thereafter ([@b39]; [@b15]; [@b32]; [@b49]; [@b62]; [@b64]; [@b13]; [@b50]). These interindividual variations in telomere length far exceed the variation in telomere length among cell types within the individual, because telomere length is synchronized (equivalent) in different tissues and cells in the fetus ([@b70]) and the newborn ([@b51]), and partially synchronized at any age ([@b20]; [@b44]; [@b71]; [@b59]; [@b31]). It follows that individuals with relatively long (or short) telomere length in one cell type have long (or short) telomere length in other cell types. Regarding telomere dynamics in leukocytes, LTL reflects birth telomere length and replicative history of HSCs/PCs. At any given time, and for whatever reason and duration, an altered demand by a leukocyte subset on PCs to increase or diminish their divisions would ultimately impact telomere dynamics in HSCs and therefore telomere length in all leukocytes. It is unlikely therefore that the racial differences in LTL may be simply explained by a subset of leukocytes. Third, in the BHS we found no association of LTL with the numbers of either leukocytes or neutrophils (Supplementary [Table S1](#SD1){ref-type="supplementary-material"}). This is not unexpected, as LTL is a record of the replicative history of HSCs/PCs over the individual\'s lifetime until sample collection, while the leukocyte and neutrophil counts reflect a 'snapshot' of the peripheral leukocytes at the time of sample collection.

Although diminished HSC/PC replication might explain the longer LTL in African Americans than in whites during early adulthood, additional factors apparently tip the balance towards narrowing the racial gap in LTL later in life. Theoretical considerations suggest that telomere attrition rate in cultured cells is proportional to telomere length ([@b19]), perhaps because longer telomeres are a greater target to free radicals. All other things being equal, the relatively longer LTL in adult African Americans may account in part for a higher rate of LTL shortening. In addition, African Americans exhibit increased prevalence of risk factors -- not only for CV disease (whose pattern may not be the same as in whites), but also for other potentially deleterious conditions, e.g. low social status and unhealthy lifestyle ([@b52]), which were shown to be associated with shortened LTL ([@b23]; [@b13]). Despite the racial differences in LTL and the rate of its shortening during adulthood, we found LTL to be heritable in both races.

Might the longer LTL in African Americans than whites provide clues with regard to racial differences in life expectancy in the USA? Until recently, a controversy existed about the relation between LTL and mortality/survival in elderly persons ([@b22]; [@b45]; [@b16]; [@b35]; [@b38]). Of these, two studies ([@b22]; [@b38]) showed an association between mortality and LTL. The other three did not. We recently addressed this question in the Longitudinal Study of Aging Danish Twins, which comprises same-sex, elderly twins, whose mortality/survival was monitored for 10 years after leukocyte collection. The same-sex twin model is the most optimal to study the connection between mortality and LTL because it controls for genes, rearing environment, sex and age, all of which might impact LTL. Using Southern blot analysis approach, it was found that the co-twin with the shorter telomere parameters was likely to die first by the 4th year of the 10 years follow-up ([@b41]). Another study reported similar findings in same-sex Swedish twins ([@b11]).

The mechanisms that define the upper boundary of lifespan -- namely, the survival of elderly individuals who withstood or did not suffer aging-related diseases during midlife -- might not be the same as those that determine aging in the general population ([@b40]). However, assuming that LTL is associated with lifespan in the elderly, there are curious observations regarding differences in mortality/survival between African Americans and whites. African Americans exhibit increased clustering of risk factors not only for CV disease but also other potentially lethal maladies; in the USA they display higher mortality rates and shorter life expectancy than whites ([@b52]). However, above the age of 70--80 years African Americans have been reported to exhibit lower mortality than whites ([@b43]; [@b67]; [@b30]; [@b27]). This crossover phenomenon was challenged due to concerns that vital statistics data reflect systematic misreporting of age among elderly African Americans ([@b24]; [@b55]). However, more recent work further supports the mortality crossover, at least with respect to coronary heart disease mortality ([@b25]). The etiology of this finding is unknown. The faster LTL shortening in African Americans would narrow the racial difference in LTL, but the vestigial effect of the LTL 'advantage' in African Americans throughout most of adult life might narrow the racial gap in mortality in the elderly.

A number of limitations of this study are noteworthy. First, this cross-sectional study is not as powerful as the longitudinal approach to examine leukocyte telomere dynamics. Second, our conclusions that LTL attrition rate is slower in African Americans than in whites between birth and early adulthood is based on indirect evidence. Third, our study focuses on the racial difference in LTL without factoring a host of race-associated circumstances that might account for the narrowing of the racial gap in LTL. However, the racial difference in LTL is of such a magnitude that it would probably eclipse the effect of any single environmental factor.

We propose that race and ethnicity should be assessed in future studies that explore the associations between diseases of aging, CV disease, in particular, and leukocyte telomere parameters.

Experimental procedures
=======================

The cohorts
-----------

The NHLBI FHS is a multicenter investigation of the genetic and epidemiologic basis of CV disease ([@b37]). Between January 2002 and January 2004, 3359 family members were studied (2737 whites, 622 African Americans). The LTL data are derived from 1968 individuals from this cohort (1163 women, 805 men, 1395 whites and 573 African Americans) with an age range of 30--93 years.

The BHS is a long-term community-based epidemiologic study of early natural history of CV disease beginning in childhood from the semirural, biracial community of Bogalusa, LA ([@b54]). Between September 1995 and December 1996, 1420 individuals (1011 whites, 409 African Americans) were examined for CV risk factors. The LTL data were derived from 485 individuals of this cohort who had stored blood available (301 women, 184 men, 247 whites and 138 African Americans) with an age range of 19--37 years.

The study protocol was approved by Institutional Review Boards of centers that oversee each of the participating cohorts and each participant gave written informed consent.

Telomere length measurements
----------------------------

The mean length of the TRFs, determined by Southern blot analysis, was used to measure LTL on DNA extracted from peripheral leukocytes. We obtained the mean TRF length in two ways: our standard method ([@b51]) and an 'overlay' method ([@b63]), both utilizing *Hin*fI/*Rsa*I restriction enzymes. (Description of the 'overlay' method, used for DNA samples derived from the FHS, is provided in the Supplementary [Appendix S1](#SD1){ref-type="supplementary-material"}.) For the standard method, the coefficient of variation for duplicate samples, which were resolved on different gels, was 1.43% while for the overlay method it was 2.40%. The correlation between the two methods was *r* = 0.99, *p* \< 0.0001 (*n* = 24). In a subset of participants, TRF length was also measured in DNA digested with restriction enzymes *Hph*I/*MnI*I. The TRF length derived from these restriction enzymes highly correlated with that derived from *Hin*fI/*Rsa*I (*r* = 0.814, *p* = 0.0001; Supplementary [Fig. S1](#SD1){ref-type="supplementary-material"}). In the same subset we also measured telomere repeats by qPCR, using minor modification ([@b31]) of the method originally described by [@b21]). The coefficient of variation for duplicate samples undergoing qPCR on different days was 6.10%. The laboratory that conducted the TRF length and qPCR assays was blinded to the identity of the subjects.

Statistical analyses
--------------------

The primary analysis consisted of comparing LTL parameters between African Americans and whites, and between men and women after adjustment for age and BMI. To investigate cross-sectional, race-specific associations of age with LTL, sex- and BMI-adjusted LTLs from each study were combined and analyzed by generalized estimating equations and an exchangeable correlation matrix (PROC GENMOD in SAS) to correct the estimated standard errors for the relatedness of the subjects within families. This correction prevents inflated significance levels of the tests used in the analyses presented. An age-by-race interaction term was included in the model to test if there were different age-related cross-sectional rates of LTL shortening between the two races. When significant, this interaction term was replaced by nesting age within race to estimate the two different slopes and their standard errors. Sex-by-age interactions with LTL shortening were not significant. Race-specific heritabilities of LTL in the FHS were obtained from SOLAR ([@b4]), adjusting for sex, age and specific gel on which the sample was run. Unless otherwise indicated, data are presented as mean ± SEM.
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**Appendix S1** Terminal restriction fragment length analysis by the overlay method (Vasan *et al*. in press).

**Fig. S1** Relationship between leukocyte telomere length, obtained using *Hph*I/*MnI*I vs. leukocyte telomere length obtained using *Hin*fI/*Rsa*I.

**Table S1** Leukocyte differential counts in a subset of the Bogalusa Heart Study by race and sex
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